PHI-401

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NamePHI-401
Drug Alias NamePHI-401
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptors antagonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsBiliary Tract NeoplasmsCarcinoma, Transitional Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPharos iBio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPharos iBio Co Ltd
Inactive CompaniesN/A
Active IndicationsBiliary Tract NeoplasmsCarcinoma, Transitional Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A